Position in GILD
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,390,226
-$213,344 QoQ
Shares Held
18,919
+1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#778
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. GILD ranks #9 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
120,434 | $30,586,622 | |
| 2 | LLY |
ELI LILLY & Co
|
22,840 | $27,394,983 | |
| 3 | ABBV |
AbbVie Inc.
|
70,717 | $17,795,225 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,665 | $12,164,452 | |
| 5 | PFE |
Pfizer Inc
|
307,330 | $7,400,506 | |
| 6 | AMGN |
Amgen Inc
|
14,884 | $5,389,794 | |
| 7 | NVS |
Novartis AG
|
28,770 | $4,508,834 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
62,967 | $3,628,158 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,390,226 | 18,919 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,603,570 | 18,681 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,504,755 | 20,407 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,160,171 | 19,461 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,378,494 | 21,453 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,554,627 | 22,799 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,131,253 | 23,073 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,941,147 | 23,153 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,601,700 | 23,345 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,816,526 | 24,799 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,748,114 | 21,579 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,634,741 | 21,814 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,795,422 | 23,296 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,991,031 | 23,997 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,342,932 | 27,291 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,215,472 | 35,913 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,061,672 | 33,355 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,975,642 | 33,232 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,165,520 | 29,824 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,260,625 | 32,364 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $2,183,137 | 31,704 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,961,132 | 30,344 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,773,434 | 30,440 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,029,978 | 32,125 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,324,126 | 30,207 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,768,522 | 23,656 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||